Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein

被引：48

作者：

Wang, Lin ^{[1
,2
]}

Wu, Yan ^{[3
]}

Yao, Sheng ^{[4
,5
]}

Ge, Huan ^{[6
]}

Zhu, Ya ^{[7
]}

Chen, Kun ^{[7
]}

Chen, Wen-zhang ^{[1
]}

Zhang, Yi ^{[1
]}

Zhu, Wei ^{[1
]}

Wang, Hong-yang ^{[2
]}

Guo, Yu ^{[8
,9
]}

Ma, Pei-xiang ^{[1
]}

Ren, Peng-xuan ^{[1
,2
]}

Zhang, Xiang-lei ^{[1
,2
]}

Li, Hui-qiong ^{[1
,2
]}

Ali, Mohammad A. ^{[10
]}

Xu, Wen-qing ^{[2
]}

Jiang, Hua-liang ^{[1
,7
]}

Zhang, Lei-ke ^{[3
]}

Zhu, Li-li ^{[2
,6
]}

Ye, Yang ^{[4
,5
]}

Shang, Wei-juan ^{[3
]}

Bai, Fang ^{[1
,2
]}

机构：

[1] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China

[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China

[3] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, State Key Lab Virol, Wuhan 430064, Peoples R China

[4] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Nat Prod Chem, Shanghai 201203, Peoples R China

[5] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[6] East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China

[7] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China

[8] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China

[9] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China

[10] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia

来源：

ACTA PHARMACOLOGICA SINICA | 2022年 / 43卷 / 04期

基金：

中国国家自然科学基金; 上海市科技启明星计划;

关键词：

SARS-CoV-2; natural products; virtual screening; spike protein; protein-protein interaction modulators; INHIBITORS; BINDING; DOCKING; ACE2;

D O I：

10.1038/s41401-021-00735-z

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

An epidemic of pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. SARS-CoV-2 relies on its spike protein to invade host cells by interacting with the human receptor protein Angiotensin-Converting Enzymes 2 (ACE2). Therefore, designing an antibody or small-molecular entry blockers is of great significance for virus prevention and treatment. This study identified five potential small molecular anti-virus blockers via targeting SARS-CoV-2 spike protein by combining in silico technologies with in vitro experimental methods. The five molecules were natural products that binding to the RBD domain of SARS-CoV-2 was qualitatively and quantitively validated by both native Mass Spectrometry (MS) and Surface Plasmon Resonance (SPR). Anti-viral activity assays showed that the optimal molecule, H69C2, had a strong binding affinity (dissociation constant K-D) of 0.0947 mu M and anti-virus IC50 of 85.75 mu M.

引用

页码：788 / 796

页数：9

共 50 条

[21] In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
Lin, Yu-Chao
Chen, Wen-Yih
Hwu, En-Te
Hu, Wen-Pin
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
[22] In silico Molecular Docking Analysis Targeting SARS-CoV-2 Spike Protein and Selected Herbal Constituents
Subbaiyan, Anbazhagan
Ravichandran, Karthikeyan
Singh, Shiv Varan
Sankar, Muthu
Thomas, Prasad
Dhama, Kuldeep
Malik, Yashpal S.
Singh, Raj Kumar
Chaudhuri, Pallab
JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 : 989 - 998
[23] Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2
Brady, Molly
Combs, Abigail
Venkatraman, Chethana
Solorzano, Alexander
Johnson, Angelique
McQuaid, Conor
Rahman, Akib
Leyva, Hannah
Kwok, Wing-Chi Edmund
Wood, Ronald W.
Deane, Rashid
COMMUNICATIONS BIOLOGY, 2021, 4 (01)
[24] Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2
Jiang, Shibo
Zhang, Xiujuan
Du, Lanying
EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (06) : 415 - 421
[25] Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
Etemadi, Ali
Moradi, Hamid Reza
Mohammadian, Farideh
Karimi-Jafari, Mohammad Hossein
Negahdari, Babak
Asgari, Yazdan
Mazloomi, Mohammadali
GENE REPORTS, 2022, 26
[26] Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2
Molly Brady
Conor McQuaid
Alexander Solorzano
Angelique Johnson
Abigail Combs
Chethana Venkatraman
Akib Rahman
Hannah Leyva
Wing-Chi Edmund Kwok
Ronald W. Wood
Rashid Deane
Communications Biology, 4
[27] Computational Design of Miniprotein Inhibitors Targeting SARS-CoV-2 Spike Protein
Wu, Jianhua
Zhang, Jilong
Zhang, Hong-Xing
LANGMUIR, 2022, 38 (34) : 10690 - 10703
[28] Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
Paul D.
Pyne N.
Paul S.
VirusDisease, 2021, 32 (4) : 703 - 726
[29] Structural Landscape of SARS-CoV-2 entry & activation of spike glycoprotein & potential interventions
Vankadari, Naveen
FASEB JOURNAL, 2022, 36
[30] Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides
Maas, Marijn N.
Hintzen, Jordi C. J.
Loffler, Philipp M. G.
Mecinovic, Jasmin
CHEMICAL COMMUNICATIONS, 2021, 57 (26) : 3283 - 3286

← 1 2 3 4 5 →